- Home
- PLX vs BSET Comparison
PLX vs BSET Comparison
Compare PLX & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- BSET
- Stock Information
- Founded
- PLX 1993
- BSET 1902
- Country
- PLX United States
- BSET United States
- Employees
- PLX N/A
- BSET N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- BSET Home Furnishings
- Sector
- PLX Health Care
- BSET Consumer Discretionary
- Exchange
- PLX Nasdaq
- BSET Nasdaq
- Market Cap
- PLX 164.2M
- BSET 135.3M
- IPO Year
- PLX 1998
- BSET 1987
- Fundamental
- Price
- PLX $2.60
- BSET $15.29
- Analyst Decision
- PLX Strong Buy
- BSET
- Analyst Count
- PLX 1
- BSET 0
- Target Price
- PLX $15.00
- BSET N/A
- AVG Volume (30 Days)
- PLX 792.6K
- BSET 24.8K
- Earning Date
- PLX 11-13-2025
- BSET 10-08-2025
- Dividend Yield
- PLX N/A
- BSET 5.21%
- EPS Growth
- PLX N/A
- BSET N/A
- EPS
- PLX 0.08
- BSET 0.28
- Revenue
- PLX $61,948,000.00
- BSET $326,469,000.00
- Revenue This Year
- PLX $14.53
- BSET $3.18
- Revenue Next Year
- PLX $75.77
- BSET $3.57
- P/E Ratio
- PLX $33.57
- BSET $54.60
- Revenue Growth
- PLX 62.79
- BSET N/A
- 52 Week Low
- PLX $0.99
- BSET $13.58
- 52 Week High
- PLX $3.10
- BSET $19.75
- Technical
- Relative Strength Index (RSI)
- PLX 82.14
- BSET 39.05
- Support Level
- PLX $1.52
- BSET $15.51
- Resistance Level
- PLX $2.12
- BSET $16.20
- Average True Range (ATR)
- PLX 0.12
- BSET 0.47
- MACD
- PLX 0.05
- BSET -0.04
- Stochastic Oscillator
- PLX 96.79
- BSET 2.42
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.